Unité de Fabrication des Médicaments S.A (BVMT:UMED)

Tunisia flag Tunisia · Delayed Price · Currency is TND
9.94
-0.06 (-0.60%)
At close: Jun 4, 2026
Market Cap318.08M +32.7%
Revenue (ttm)149.02M +0.8%
Net Income18.60M -4.0%
EPSn/a
Shares Out 32.00M
PE Ratio17.10
Forward PE18.75
Dividend0.57 (5.73%)
Ex-Dividend Daten/a
Volume53,141
Open10.06
Previous Close10.00
Day's Range9.86 - 10.06
52-Week Range7.11 - 10.30
Beta0.18
Analystsn/a
Price Targetn/a
Earnings DateJun 12, 2026

About BVMT:UMED

Unité de Fabrication des Médicaments S.A. develops, manufactures, markets, and sells generic and fashioned medicines in Tunisia and internationally. The company offers ophthalmic, ENT, inhalation and infusion solutions, injectable fluids and penicillin, and cephalosporin powders for various therapeutic areas under the UNIMED brand name. It exports its products to Africa, Asia, and Europe. The company was founded in 1989 and is headquartered in Sousse, Tunisia. [Read more]

Industry Pharmaceutical Preparations
Founded 1989
Employees 572
Stock Exchange Tunis Stock Exchange
Ticker Symbol UMED
Full Company Profile

Financial Performance

In 2025, BVMT:UMED's revenue was 149.02 million, an increase of 0.91% compared to the previous year's 147.68 million. Earnings were 18.60 million, a decrease of -3.98%.

Financial Statements